Related Experiment Videos
[Cytopherometry in neurologic diseases (author's transl)]
Fortschritte Der Neurologie, Psychiatrie, Und Ihrer Grenzgebiete
|November 1, 1977
Summary
Cytopherometry techniques, including the Macrophage-Electrophoresis-Mobility (MEM) test, reveal immune cell changes in neurologic diseases. These methods offer diagnostic insights into neuroinflammatory conditions and brain tumors.
Area of Science:
- Neuroimmunology
- Cellular immunology
- Diagnostic techniques
Context:
- Neurologic diseases involve complex immune responses.
- Assessing immune cell behavior is crucial for diagnosis and understanding pathogenesis.
- Existing diagnostic methods may not fully capture the nuances of neuroimmune interactions.
Purpose:
- To explore the utility of cytopherometry in diagnosing and understanding neurologic diseases.
- To evaluate the Macrophage-Electrophoresis-Mobility (MEM) test and its variants for immunopathologic assessment.
- To investigate specific immune factors like thymosine and macrophage slowing factor (MSF) in CSF.
Summary:
- Cytopherometry, particularly the MEM test, analyzes antigenic reactivity, cytokine formation, and immune cell electrophoretic mobility in neurologic conditions.
- The MEM-LAD test identified characteristic findings in Multiple Sclerosis (MS), suggesting novel pathogenetic and therapeutic insights.
- Analysis extended to thymosine and MSF assays, revealing significant MSF activity in CSF of chronic neuroimmunologic diseases, especially MS.
Impact:
- Provides valuable diagnostic and immunopathologic information for various neurologic diseases, including MS and brain tumors.
- Highlights the potential of MEM test variants for detecting general sensitization and specific reactivity in nervous system lesions.
- Advances understanding of CSF immunology and the role of cytokines in chronic neuroimmunologic processes, with implications for myasthenia gravis and thymectomy.